Point of Care – Rapid Antigen Test

Point of Care – Rapid Antigen Test

Due to the highly contagious nature and global health crises, SARS-CoV-2 has been designated as a pandemic by the World Health Organization (WHO) and continues to have devastating impacts on healthcare systems and the world economy including the U.S.To effectively end the SARS-CoV-2 pandemic, systematic screening and detection of clinical COVID-19 cases is critical. An effective screening regimen in a workplace, campus or other community setting can be established using the quick results provided by antigen tests.As an intended point-of-care (POC) designated test with a 10 min processing time, CareStart™ COVID-19 Antigen Test allows effective screening of COVID-19 infection on a large scale.


  • Lateral flow assay
  • No equipment required
  • Rapid results within 10 minutes
  • Minimally invasive specimen collection(nasopharyngeal)
  • Intended at POC setting bymedical professionals

Clinical Features

  • Detect SARS-CoV-2 nucleocapsid protein antigen with ultra high performance
  • Identify acute infection with high sensitivity and 100% specificity

Test Principles

The CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in nasopharyngeal and nasal swab specimens directly collected from individuals who are suspected of COVID-19 by their healthcare providers.



Peel off aluminum foil seal and rotate the swab inside the extraction vial vigorously at least 5 times


Remove the swab, close the vial by pushing the cap onto the vial and squeeze the vial gently to release 3 drops of sample to the sample well.


Read the test results between10 and 15 minutes

Results Interpretation


  • The color intensity in the test region will vary depending on the amount of SARS-CoV-2 antigen present in the sample.
  • Any faint colored line in the test region should be considered as positive.